Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Tax Rate (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Tax Rate for 16 consecutive years, with 21.13% as the latest value for Q4 2025.

  • Quarterly Tax Rate rose 43.0% to 21.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 21.71% through Dec 2025, down 23842.0% year-over-year, with the annual reading at 21.71% for FY2025, 23842.0% down from the prior year.
  • Tax Rate hit 21.13% in Q4 2025 for Ligand Pharmaceuticals, up from 16.91% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 160.21% in Q4 2022 to a low of 214.12% in Q1 2021.
  • Historically, Tax Rate has averaged 7.13% across 5 years, with a median of 18.76% in 2024.
  • Biggest five-year swings in Tax Rate: plummeted -23478bps in 2021 and later surged 17273bps in 2022.
  • Year by year, Tax Rate stood at 22.83% in 2021, then surged by 602bps to 160.21% in 2022, then tumbled by -104bps to 6.38% in 2023, then soared by 424bps to 20.69% in 2024, then increased by 2bps to 21.13% in 2025.
  • Business Quant data shows Tax Rate for LGNDZ at 21.13% in Q4 2025, 16.91% in Q3 2025, and 56.81% in Q2 2025.